NCT04215913View on ClinicalTrials.gov

Integrative Analysis of Pulmonary Sarcomatoid Carcinoma (PSC)

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 30, 2019

Primary Completion Date

December 24, 2025

Study Completion Date

December 24, 2025

Conditions
Lung Cancer
Interventions
OTHER

The investigators will extract total protein, DNA and RNA from PSC patients.

The investigators will extract total protein, DNA and RNA from PSC patients.

Trial Locations (1)

200072

Da Fu, Shanghai

All Listed Sponsors
collaborator

The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China

OTHER

collaborator

Anhui Medical University

OTHER

lead

Shanghai 10th People's Hospital

OTHER